Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers

References

• International Agency for Research on Cancer, World Health Organization. Schistosomiasis, liver flukes and Helicobacter pylori. IARC working group on the evaluation of carcinogenic risks to human. Monogr Eval Carcinog Risks Hum 1994;61:218–20.
   Google Scholar
• Valle J, Kekki M, Sipponen P, Ihamäki T, Siurala M. Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand J Gastroenterol 1996;31:546–50.
   PubMed Web of Science ®Google Scholar
• Kuipers EJ, Uyterlinde AM, Peña AS, Roosendaal R, Pals G, Nelis GF, Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995;345:1525–8.
   PubMed Web of Science ®Google Scholar
• Correa P, Haenszel W, Cuello C, Zavala D, Fontham E, Zarama G, Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res 1990;50:4737–40.
   PubMed Web of Science ®Google Scholar
• Malfertheiner P, Sipponen P, Naumann M, Moayyedi P, Mégraud F, Xiao SD, Lejondal H. pylori-Gastric Cancer Task Force. Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique. Am J Gastroenterol 2005;100:2100–15.
   PubMed Web of Science ®Google Scholar
• Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784–9.
   PubMed Web of Science ®Google Scholar
• Filipe MI, Munoz N, Matko I, Kato I, Pompe-Kirn V, Jutersek A, Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer 1994;57:324–9.
   PubMed Web of Science ®Google Scholar
• Sipponen P, Kekki M, Haapakoski J, Ihamäki T, Siurala M. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 1985;35:173–7.
   PubMed Web of Science ®Google Scholar
• Ohata H, Kitauchi S, Yoshimura N, Mugitani K, Iwane M, Nakamura H, Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004;109:138–43.
   PubMed Web of Science ®Google Scholar
• Varis K, Sipponen P, Laxen F, Samloff IM, Huttunen JK, Taylor PR, and The Helsinki Gastritis Study Group. Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia. Scand J Gastroenterol 2000;35:950–6.
   PubMed Web of Science ®Google Scholar
• Kimura K, Satoh K, Ido K, Taniguchi Y, Takimoto T, Takemoto T. Gastritis in the Japanese stomach. Scand J Gastroenterol 1996;214:17–20.
   Google Scholar
• Storskrubb T, Aro P, Ronkainen J, Sipponen P, Nyhlin H, Talley NJ, Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: the Kalixanda study. Scand J Gastroenterol 2008;43:1448–55.
   PubMed Web of Science ®Google Scholar
• Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, China Gastric Cancer Study Group. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004;291:187–94.
   PubMed Web of Science ®Google Scholar
• Kosunen TU, Pukkala E, Sarna S, Seppälä K, Aromaa A, Knept P, Gastric cancer in Finnish patients after cure of Helicobacter pylori infection: a cohort study. Int J Cancer 2011;128:433–9.
   PubMed Web of Science ®Google Scholar
• Yeh JM, Kuntz KM, Ezzati M, Goldie SJ. Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results. Int J Cancer 2009;124:157–66.
   PubMed Web of Science ®Google Scholar
• Sipponen P, Helske T, Järvinen P, Hyvärinen H, Seppälä K, Siurala M. Fall in the prevalence of chronic gastritis over 15 years: analysis of outpatient series in Finland from 1977, 1985, and 1992. Gut 1994;35:1167–71.
   PubMed Web of Science ®Google Scholar
• Maaroos HI, Vorobjova T, Sipponen P, Tammur R, Uibo R, Wadström T, An 18-year follow-up study of chronic gastritis and Helicobacter pylori association of CagA positivity with development of atrophy and activity of gastritis. Scand J Gastroenterol 1999;34:864–9.
   PubMed Web of Science ®Google Scholar
• Yananoka K, Oka M, Ohata H, Yoshimura N, Deguchi H, Mukoybayashi C, Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels. Int J Cancer 2009;125:2697–703.
   PubMedGoogle Scholar
• de Vries AC, van Grieken NCT, Looman CWN, Casparie MK, de Vries E, Meijer GA, Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology 2008;134:945–52.
   PubMed Web of Science ®Google Scholar
• Miki K, Fujishiro M, Kodashima S, Yahagi N. Long-term results of gastric cancer screening using the the serum pepsinogen test method among an asymptomatic middle-aged Japanese population. Dig Endosc 2009;21:78–81.
   PubMed Web of Science ®Google Scholar
• Kokkola A, Sjöblom SM, Haapiainen R, Sipponen P, Puolakkainen P, Järvinen H. The risk of gastric carcinoma and carcinoid tumours in patients with pernicious anaemia. A prospective follow-up study. Scand J Gastroenterol 1998;33:88–92.
   PubMed Web of Science ®Google Scholar
• Telaranta-Keerie A, Kara R, Paloheimo L, Härkönen M, Sipponen P. Prevalence of undiagnosed advanced atrophic corpus gastritis in Finland: an observational study among 4,256 volunteers without specific complaints. Scand J Gastroenterol 2010;45:1036–41.
   PubMed Web of Science ®Google Scholar
• Sipponen P, Laxen F, Huotari K, Härkönen M. Prevalence of low vitamin B12 and high homocysteine in serum in an elderly male population: association with atrophic gastritis and Helicobacter pylori infection. Scand J Gastroenterol 2003;38:1209–16.
   PubMed Web of Science ®Google Scholar
• Sipponen P, Härkönen M. Hypochlorhydric stomach: a risk condition for calcium malabsorption and osteoporosis? Scand J Gastroenterol 2010;45:133–8.
   PubMed Web of Science ®Google Scholar
• Dinis-Ribeiro M, da Costa-Pereira A, Lopes C, Barbosa J, Guilherme M, Moreira-Dias L, Validity of serum pepsinogen I/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma. Neoplasia 2004;6:449–56.
   PubMed Web of Science ®Google Scholar
• Borch K, Axelsson CK, Halgreen H, Damkjaer Nielsen MD, Ledin T, Szesci PB. The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. Scand J Gastroenterol 1989;24:870–6.
   PubMed Web of Science ®Google Scholar
• Dinis-Ribeiro M, Yamaki G, Miki K, Costa-Pereira A, Matsukawa M, Kurihara M. Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening. J Med Screen 2004;11:141–7.
   PubMed Web of Science ®Google Scholar
• Miki K, Morita M, Sasajima M, Hoshina R, Kanda E, Urita Y. Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroenterol 2003;98:735–9.
   PubMed Web of Science ®Google Scholar
• Varis K, Isokoski M. Screening of type A gastritis. Ann Clin Res 1981;13:133–8.
   PubMedGoogle Scholar
• Sipponen P, Ranta P, Helske T, Kääriäinen I, Mäki T, Linnala A, Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study. Scand J Gastroenterol 2002;37:785–91.
   PubMed Web of Science ®Google Scholar
• Sipponen P, Valle J, Varis K, Kekki M, Ihamäki T, Siurala M. Fasting levels of serum gastrin in different functional and morphologic states of the antrofundal mucosa. An analysis of 860 subjects. Scand J Gastroenterol 1990;25:513–19.
   PubMed Web of Science ®Google Scholar
• Varis K, Kekki M, Härkönen M, Sipponen P, Samloff IM. Serum pepsinogen I and serum gastrin in the screening of atrophic pangastritis with high risk of gastric cancer. Scand J Gastroenterol 1991;186:117–23.
   Web of Science ®Google Scholar
• den Hartog G, Jansen JB, Schaardenburg DJ, Lamferts EJ, van de Boomgard RM, Kreuning J, Plasma gastrin responses to bombesin and antral gastrin concentrations in patients with intestinal type of gastric cancer. Cancer Res 1988;48:2296–8.
   PubMedGoogle Scholar
• Sipponen P, Vauhkonen M, Helske T, Kääriäinen I, Härkönen M. Low circulating levels of gastrin-17 in patients with Barrett's esophagus. World J Gastroenterol 2005;11:5988–92.
   PubMed Web of Science ®Google Scholar
• Rugge M, Correa P, Di Mario F, El-Omar E, Fiocca R, Geboes K, OLGA staging for gastritis: a tutorial. Dig Liver Dis 2008;40:650–8.
   PubMedGoogle Scholar
• Rugge M, de Boni M, Pennelli G, de Bona M, Giacomelli L, Fassan M, Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ther 2010;31:1104–11.
   PubMed Web of Science ®Google Scholar
• Carmel R. Prevalence of undiagnosed pernicious anemia in the elderly. Arch Intern Med 1996;156:1097–100.
   PubMedGoogle Scholar
• Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, Bloemena EC, Sandell M, Nelis GF, Atrophic gastritis during long-term omeprazole therapy affects serum vitamin B12 levels. Aliment Pharmacol Ther 1999;13:1343–6.
   PubMed Web of Science ®Google Scholar
• Sharma VE, Brannon MA, Carloss EA. Effect of omeprazole on oral iron replacement in patients with iron deficiency anemia. South Med J 2004;97:887–9.
   PubMed Web of Science ®Google Scholar
• Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 2006;296:2947–53.
   PubMed Web of Science ®Google Scholar
• Ozutemiz AO, Aydin HH, Isler M, Celik HA, Batur Y. Effect of omeprazole on plasma zinc levels after oral zinc administration. Indian J Gastroenterol 2002;21:216–18.
   PubMedGoogle Scholar
• Bolander-Gouaille C. Focus on Homocysteine and the Vitamins involved in its Metabolism. Berlin: Springer Verlag; 2002.
   Google Scholar
• Derendorf H, VanderMaelen CP, Bricki RS, MacGregor TR, Eisert W. Dipyridamole bioavailability in subjects with reduced gastric acidity. J Clin Pharmacol 2005;45:845–50.
   PubMed Web of Science ®Google Scholar
• Lim SG, Sawyerr AM, Hudson M, Sercombe J, Pounder RE. Short report: the absorption of fluconazoli and itraconazoli under conditions of low intragastric acidity. Aliment Pharmacol Ther 1993;7:317–21.
   PubMed Web of Science ®Google Scholar
• Centanni M, Gargano L, Canettieri G, Viceconti N, Franchi A, Delle Fave G, Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N Engl J Med 2006;354:1787–95.
   PubMed Web of Science ®Google Scholar
• Tomilo DL, Smith PF, Ogundale AB, Difrancesco R, Berenson CS, Eberhardt E, Inhibition of atazanavir oral absorption by lanzoprazole gastric acid suppression in healthy volunteers. Pharmacotherapy 2006;26:341–6.
   PubMed Web of Science ®Google Scholar
• Martinsen TC, Bergh K, Waldum HL. Gastric juice: a barrier against infectious diseases. Basic Clin Pharmacol Toxicol 2005;96:94–102.
   PubMed Web of Science ®Google Scholar
• Duchini A, Rogers VD. Diarrhea in the international traveler. Curr Treat Options Gastroenterol 1999;2:251–7.
   PubMedGoogle Scholar
• Cunnigham R, Dale B, Undy B, Gaunt N. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect 2003;54:243–5.
   PubMedGoogle Scholar
• Tryba M. The gastropulmonary route of infection – fact or fiction. Am J Med 1991;91:135S–46S.
   Google Scholar
• Stockbruegger RW, Cotton PB, Menon GG. Pernicious anaemia, intragastric bacterial overgrowth and possible consequences. Scand J Gastroenterol 1984;19:355–64.
   PubMed Web of Science ®Google Scholar
• Salaspuro M. Acetaldehyde as a common denominator and cumulative carcinogen in digestive tract cancers. Scand J Gastroenterol 2009;44:912–25.
   PubMed Web of Science ®Google Scholar
• Salaspuro M. Acetaldehyde and gastric cancer. J Dig Dis 2011;12:51–9.
   PubMed Web of Science ®Google Scholar
• Jakszyn P, Conzales CA. Nitrosamine and related food intake and gastric and oesophageal cancer risk: a systematic review of the epidemiological evidence. World J Gastroenterol 2006;12:4296–303.
   PubMed Web of Science ®Google Scholar
• Secretan B, Straif K, Baan R. A review of human carcinogens-Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 2009;110:1033–4.
   Google Scholar
• Seitz HK, Stickel F. Acetaldehyde as an underestimated risk factor for cancer development: role of genetics in ethanol metabolism. Genes Nutr 2009;5:121–2.
   PubMedGoogle Scholar
• Yang S-J, Wang H-Y, Li X-Q. Genetic polymorphisms of ADH2 and ALDH2 association with esophageal cancer risk in southwest China. World J Gastroenterol 2007;13:5760–4.
   PubMed Web of Science ®Google Scholar
• Lee C-H, Lee J-M, Goan Y-G. Carcinogenetic impact of ADH1B and ALDH2 genes on squamous cell carcinoma risk of the esophagus with regard to the consumption of alcohol, tobacco and betel quid. Int J Cancer 2008;122:1347–56.
   PubMed Web of Science ®Google Scholar
• Yang S-J, Yokoyama A, Yokoyama T. Relationship between genetic polymorphisms of ALDH2 and ADH1B and esophageal cancer risk: a meta-analysis. World J Gastroenterol 2010;16:4210–20.
   PubMed Web of Science ®Google Scholar
• Yokoyama A, Yokoyama T, Omori T. Helicobacter pylori, chronic atrophic gastritis, inactive aldehyde dehydrogenase-2, macrocytosis and multiple upper aerodigestive cancers and the risk for gastric cancer in alcoholic Japanese men. J Gastroenterol Hepatol 2007;22:210–17.
   PubMed Web of Science ®Google Scholar
• Väkeväinen S, Mentula S, Nuutinen H. Ethanol-derived microbial production of carcinogenic acetaldehyde in achlorhydric atrophic gastritis. Scand J Gastroenterol 2002;37:648–55.
   PubMed Web of Science ®Google Scholar
• Väkeväinen S, Tillonen J, Salaspuro M, Jousimies-Somer H, Nuutinen H, Färkkilä M. Hypochlorhydria induced by a proton pump inhibitor leads to intragastric microbial production of acetaldehyde from ethanol. Aliment Pharmacol Ther 2000;14:1511–18.
   PubMed Web of Science ®Google Scholar
• Bode JC, Rust S, Bode C. The effect of cimetidine treatment on ethanol formation in the human stomach. Scand J Gastroenterol 1984;19:853–6.
   PubMed Web of Science ®Google Scholar
• Roine RP, Salmela KS, Höök-Nikanne J, Kosunen TU, Salaspuro M. Alcohol dehydrogenase mediated acetaldehyde production by Helicobacter pylori – a possible mechanism behind gastric injury. Life Sci 1992;51:1333–7.
   PubMed Web of Science ®Google Scholar
• Salaspuro V, Salaspuro M. Synergistic effect of alcohol drinking and smoking on in vivo acetaldehyde concentration in saliva. Int J Cancer 2004;111:480–3.
   PubMed Web of Science ®Google Scholar
• Chao A, Thun MJ, Henley J, Jacobs EJ, McCullough ML, Calle EE. Cigarette smoking, use of other tobacco products and stomach cancer mortality in US adults: The cancer prevention study II. Int J Cancer 2002;101:380–90.
   PubMed Web of Science ®Google Scholar
• Conzales CA, Pera G, Agudo A. Smoking and the risk of gastric cancer in the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 2003;107:629–33.
   PubMedGoogle Scholar
• Sjodahl K, Lu Y, Nilsen TI, Hveem K, Lagergren J. Smoking and alcohol drinking in relation to risk of gastric cancer: a population-based prospective cohort study. Int J Cancer 2007;120:128–32.
   PubMed Web of Science ®Google Scholar
• Shikata K, Doi Y, Yonemoto K. Population-based prospective study of the combined influence of cigarette smoking and Helicobacter pylori infection on gastric cancer incidence. Am J Epidemiol 2008;168:1409–15.
   PubMed Web of Science ®Google Scholar
• Hoffman D, Hoffman I. The changing cigarette; chemical studies and bioassays, in Smoking and Tobacco Control Monograph no. 13: Risks associated with smoking with low machine-measured yields of tar and nicotine. Bethesda, MD, USA: National Cancer Institute; 2002. pp 159–92.
   Google Scholar
• Linderborg K, Marvola T, Marvola M, Salaspuro M, Färkkilä M, Väkeväinen S. Reducing carcinogenic acetaldehyde exposure in the achlorhydric stomach with cysteine. Alcohol Clin Exp Res 2011;35:516–22.
   PubMedGoogle Scholar
• Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC: CancerBase No. 9. http://globocan.iarc.fr. (Cited 21 February 2011).
   Google Scholar
• Capelle LG, van Grieken NCT, Lingsma HF, Steyerberg EW, Klokman WJ, Bruno MJ, Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands. Gastroenterology 2010;136:487–92.
   Google Scholar
• van Lier MG, Mathus-Vliegen EM, Wagner A, van Leerdam ME, Kuipers EJ. High cumulative risk of intussusceptions in patients with Peutz-Jeghers syndrome: time to update surveillance guidelines? Am J Gastroenterol 2010;106:940–5.
   PubMedGoogle Scholar
• Mecklin JP, Nordling S, Saario I. Carcinoma of the stomach and its heredity in young patients. Scand J Gastroenterol 1988;23:307–11.
   PubMed Web of Science ®Google Scholar
• de Vries AC, van Driel HF, Richardus JH, Ouwendijk M, van Vuuren AJ, de Man RA, Migrant communities a possible target population for primary prevention of Helicobacter pylori – related complications in low incidence countries. Scand J Gastroenterol 2008;43:403–9.
   PubMed Web of Science ®Google Scholar
• Sande N, Nikulin M, Nilsson I, Wadström T, Laxen F, Härkönen M, Increased risk of developing atrophic gastritis in patients infected with CagA+ Helicobacter pylori. Scand J Gastroenterol 2001;36:928–33.
   PubMed Web of Science ®Google Scholar
• Aromaa A, Kosunen TU, Knekt P, Maatela J, Teppo L, Heinonen OP, Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer. Am J Epidemiol 1996;144:142–9.
   PubMed Web of Science ®Google Scholar
• Annibale B, Negrini R, Caruana P, Lehner E, Crossi C, Bordi C, Two-thirds of atrophic body gastritis have evidence of Helicobacter pylori infection. Helicobacter 2001;6:225–33.
   PubMed Web of Science ®Google Scholar
• Singh K, Ghoshal UC. Causal role of Helicobacter pylori infection in gastric cancer: an Asian enigma. World J Gastroenterol 2006;12:1346–51.
   PubMed Web of Science ®Google Scholar
• Ghoshal UC, Chaturvedi R, Correa P. The enigma of Helicobacter pylori infection and gastric cancer. Indian J Gastroenterol 2010;29:95–100.
   PubMedGoogle Scholar
• Yokoyama A, Muramatsu T, Ohmori T, Yokoyama T, Okoyama K, Makuuchi H, Alcohol-related cancers and aldehyde dehydrogenase-2 in Japanese alcoholics. Carcinogenesis 1998;19:1383–7.
   PubMed Web of Science ®Google Scholar
• Sipponen P, Graham DY. Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers. Scand J Gastroenterol 2007;42:2–10.
   PubMed Web of Science ®Google Scholar
• Hashibe M, Boffetta P, Zaridze D, Shangina O, Szeszenia-Dobrowska N, Mates D, Evidence for an important role of alcohol- and aldehyde-metabolizing genes in cancers of the upper aerodigestive tract. Cancer Epidemiol Biomarkers Prev 2006;15:696–703.
   PubMed Web of Science ®Google Scholar
• Zhang FF, Hou L, Terry MB, Lissowska J, Morabia A, Chen J, Genetic polymorphisms in alcohol metabolism, alcohol intake and the risk of stomach cancer in Warsaw, Poland. Int J Cancer 2007;121:2060–4.
   PubMed Web of Science ®Google Scholar
• Sipponen P, Correa P. Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M/F) pattern: etiologic hypothesis. Gastric Cancer 2002;5:213–19.
   PubMedGoogle Scholar
• Karnes WE Jr, Samloff IM, Siurala M, Kekki M, Sipponen P, Kim SW, Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 1991;101:167–74.
   PubMed Web of Science ®Google Scholar
• Graham DY, Opekun AR, Hammoud F, Yamaoka Y, Reddy R, Osato MS, Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors. Am J Gastroenterol 2003;98:1005–9.
   PubMed Web of Science ®Google Scholar
• Murakami K, Sato R, Okimoto T, Watanabe K, Nasu M, Fujioka T, Influence of anti-ulcer drugs used in Japan on the result of (13)C-urea breath test for the diagnosis of Helicobacter pylori infection. J Gastroenterol 2003;38:937–41.
   PubMed Web of Science ®Google Scholar
• Kokkola A, Rautelin H, Puolakkainen P, Sipponen P, Färkkilä M, Haapiainen R, Diagnosis of Helicobacter pylori infection in patients with atrophic gastritis: comparison of histology, 13C-urea breath test, and serology. Scand J Gastroenterol 2000;35:138–41.
   PubMed Web of Science ®Google Scholar
• Salomaa-Räsänen A, Kosunen TU, Mattila J, Sarna S, Rautelin H. Age-dependent accuracy of Helicobacter pylori antibody assays for adults, with special emphasis on atrophic gastritis. Clin Diagn Lab Immunol 2004;11:1185–8.
   PubMedGoogle Scholar
• Kokkola A, Kosunen TU, Puolakkainen P, Sipponen P, Härkönen M, Laxen F, Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis. APMIS 2003;111:619–24.
   PubMed Web of Science ®Google Scholar
• Perri F, Ricciardi R, Merla A, Piepoli A, Gasperi V, Quitadamo M, Appropriateness of urea breath test: a prospective observational study based on Maastricht 2000 guidelines. Aliment Pharmacol Ther 2002;16:1443–7.
   PubMed Web of Science ®Google Scholar
• Kokkola A, Rautelin H, Puolakkainen P, Sipponen P, Färkkilä M, Haapiainen R, Positive result by serology indicates active Helicobacter pylori infection in patients with atrophic gastritis. J Clin Microbiol 1998;36:1808–10.
   PubMed Web of Science ®Google Scholar
• Malfertheiner P, Mégraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772–81.
   PubMed Web of Science ®Google Scholar
• Sung JJ, Lao WC, Lai MS, Li TH, Chan FK, Wu JC, Incidence of gastroesophageal malignancy in patients with dyspepsia in Hong Kong: implications for screening strategies. Gastrointest Endosc 2001;54:454–8.
   PubMed Web of Science ®Google Scholar
• Li XB, Liu WZ, Ge ZZ, Chen XY, Shi Y, Xiao SD. Helicobacter pylori “test-and-treat” strategy is not suitable for the management of patients with uninvestigated dyspepsia in Shanghai. Scand J Gastroenterol 2005;40:1028–31.
   PubMed Web of Science ®Google Scholar
• Bai Y, Li ZS, Zou DW, Wu RP, Yao YZ, Jin ZD, Alarm features and age for predicting upper gastrointestinal malignancy in Chinese patients with dyspepsia with high background prevalence of Helicobacter pylori infection and upper gastrointestinal malignancy: en endoscopic database review of 102,665 patients from 1996–2006. Gut 2010;59:722–8.
   PubMedGoogle Scholar
• Liou JM, Lin JT, Wang SP, Huang SP, Lee YC, Shun CT, The optimal age threshold for screening upper endoscopy for uninvestigated dyspepsia in Taiwan, an area with a higher prevalence of gastric cancer in young adults. Gastrointest Endosc 2005;61:819–25.
   PubMedGoogle Scholar
• Farinati F, Di Mario F, Plebani M, Cielo R, Fanton MC, Valiante F, Pepsinogen A/pepsinogen C or pepsinogen A multiplied by gastrin in the diagnosis of gastric cancer? Ital J Gastroenterol 1991;23:194–6.
   PubMedGoogle Scholar
• Kuipers EJ, Pals G, Pena AS, van Uffelen CW, Kok A, Westerveld BD, Helicobacter pylori, pepsinogens and gastrin: relationship with age and development of atrophic gastritis. Eur J Gastroenterol Hepatol 1996;8:153–6.
   PubMed Web of Science ®Google Scholar
• Kikuchi R, Abe Y, Iijima K, Koike T, Ara N, Uno K, Low serum levels of pepsinogen and gastrin 17 are predictive of extensive gastric atrophy with high risk of early gastric cancer. Tohoku J Exp Med 2011;223:35–44.
   PubMedGoogle Scholar
• Väänänen H, Vauhkonen M, Helske T, Kääriäinen I, Rasmussen M, Tunturi-Hihnala H, Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol 2003;15:885–91.
   PubMed Web of Science ®Google Scholar
• Broutet N, Plebani M, Sakarovitch C, Sipponen P, Megraud F; and Eurohepygast Study Group. Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics. Br J Cancer 2003;88:1239–47.
   PubMed Web of Science ®Google Scholar
• Knight T, Wyatt J, Wilson A, Greaves S, Newell D, Hengels K, Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in high risk groups. Br J Cancer 1996;73:819–24.
   PubMed Web of Science ®Google Scholar
• Di Mario F, Moussa AM, Caruana P, Merli R, Cavallaro LG, Cavestro GM, 'Serological biopsy' in first-degree relatives of patients with gastric cancer affected by Helicobacter pylori infection. Scand J Gastroenterol 2003;38:1223–7.
   PubMed Web of Science ®Google Scholar
• Pasechnikov VD, Chukov SZ, Kotelevets SM, Mostovov AN, Mernova VP, Polyakova MB. Possibility of non-invasive diagnosis of gastric mucosal precancerous changes. World J Gastroenterol 2004;10:3146–50.
   PubMed Web of Science ®Google Scholar
• Korstanje A, den Hartog G, Biemond I, Lamers CB. The serological gastric biopsy: a non-endoscopical diagnostic approach in management of the dyspeptic patient: significance for primary care based on a survey of the literature. Scand J Gastroenterol 2002;236(Suppl):22–6.
   Google Scholar
• Mardh E, Mardh S, Mardh B, Borch K. Diagnosis of gastritis by means of a combination of serological analyses. Clin Chim Acta 2002;320:17–27.
   PubMed Web of Science ®Google Scholar
• Kiyohira K, Yoshihara M, Ito M, Haruma K, Tanaka S, Chayama K. Serum pepsinogen concentration as a marker of Helicobacter pylori infection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels. J Gastroenterol 2003;38:332–8.
   PubMed Web of Science ®Google Scholar
• Bodger K, Wyatt JI, Heatley RV. Variation in serum pepsinogens with severity and topography of Helicobacter pylori-associated chronic gastritis in dyspeptic patients referred for endoscopy. Helicobacter 2001;6:216–24.
   PubMed Web of Science ®Google Scholar
• Urita Y, Hike K, Torii N, Kikuchi Y, Kanda E, Sasajima M, Serum pepsinogens as a predicator of the topography of intestinal metaplasia in patients with atrophic gastritis. Dig Dis Sci 2004;49:795–801.
   PubMed Web of Science ®Google Scholar
• Kitahara F, Kobayashi K, Sato T. Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut 1999;44:693–7.
   PubMed Web of Science ®Google Scholar
• Shiotani A, Iishi H, Uedo N, Kumamoto M, Nakae Y, Ishiguro S, Histologic and serum risk markers for noncardia early gastric cancer. Int J Cancer 2005;115:463–9.
   PubMed Web of Science ®Google Scholar
• Di Mario F, Cavallaro LG, Moussa AM, Caruana P, Merli R, Maini A, Usefulness of serum pepsinogens in Helicobacter pylori chronic gastritis: relationship with inflammation, activity, and density of the bacterium. Dig Dis Sci 2006;51:1791–5.
   PubMed Web of Science ®Google Scholar
• Yanaoka K, Oka M, Yoshimura N, Mukoubayashi C, Enomoto S, Iguchi M, Risk of gastric cancer in asymptomatic, middle-aged Japanese subjects based on serum pepsinogen and Helicobacter pylori antibody levels. Int J Cancer 2008;123:917–26.
   PubMed Web of Science ®Google Scholar
• de Vries AC, Haringsma J, de Vries RA, ter Borg F, van Grieken NCT, Meijer GA, Biopsy strategy for endoscopic surveillance of premalignant gastric lesions. Helicobacter 2010;15:259–64.
   PubMed Web of Science ®Google Scholar
• Agréus L, Storskrubb T, Aro P, Ronkainen J, Talley NJ, Sipponen P. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population. Scand J Gastroenterol 2009;44:564–70.
   PubMed Web of Science ®Google Scholar